SEC Filings | BioNTech

Filing date	Description	Form	View
27 January 2020	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	0000950123-20-000526.pdf 0000950123-20-000526.rtf 0000950123-20-000526.xls View HTML
28 January 2020	UPLOAD	UPLOAD	0000000000-20-000758.pdf 0000000000-20-000758.rtf View HTML
3 February 2020	Registration statement for certain foreign private issuers	F-1	0001193125-20-022991.pdf 0001193125-20-022991.rtf 0001193125-20-022991.xls View HTML
3 February 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001193125-20-023078.pdf 0001193125-20-023078.rtf 0001193125-20-023078.xls View HTML
3 February 2020	CORRESP	CORRESP	0001193125-20-023027.pdf 0001193125-20-023027.rtf 0001193125-20-023027.xls View HTML
3 February 2020	CORRESP	CORRESP	0001193125-20-023031.pdf 0001193125-20-023031.rtf 0001193125-20-023031.xls View HTML
5 February 2020	EFFECT	EFFECT	9999999995-20-000265.pdf 9999999995-20-000265.rtf 9999999995-20-000265.xls View HTML
7 February 2020	Withdrawal of registration statement filed under the Securities Act	RW	0001193125-20-028130.pdf 0001193125-20-028130.rtf 0001193125-20-028130.xls View HTML
12 February 2020	A statement of beneficial ownership of common stock by certain persons	SC 13G	0001193125-20-033238.pdf 0001193125-20-033238.rtf 0001193125-20-033238.xls View HTML
13 February 2020	A statement of beneficial ownership of common stock by certain persons	SC 13G	0001193125-20-035059.pdf 0001193125-20-035059.rtf 0001193125-20-035059.xls View HTML

Data provided by Kaleidoscope.